First Time Loading...

Instem PLC
LSE:INS

Watchlist Manager
Instem PLC Logo
Instem PLC
LSE:INS
Watchlist
Price: 830 GBX Market Closed
Updated: Apr 28, 2024

Profitability Summary

Instem PLC's profitability score is 50/100. We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

50/100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

50/100
Profitability
Score
50/100
Profitability
Score

Past Growth

To be successful and remain in business, both growth and profitability are important and necessary. Net Income growth is often seen as a sign of a company's efficiency from an operational standpoint, but is influenced heavily by a company's goals and challenges and should therefore be assessed in conjunction with other metrics like revenue and operating income growth.

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Earnings Waterfall
Instem PLC

Revenue
60.4m GBP
Operating Expenses
-54.1m GBP
Operating Income
6.3m GBP
Other Expenses
-2.9m GBP
Net Income
3.4m GBP

Margins Comparison
Instem PLC Competitors

Country Company Market Cap Operating
Margin
Net
Margin
UK
Instem PLC
LSE:INS
190m GBP
10%
6%
US
Veeva Systems Inc
NYSE:VEEV
32.4B USD
18%
22%
US
Cerner Corp
NASDAQ:CERN
27.9B USD
13%
10%
US
Change Healthcare Inc
NASDAQ:CHNG
9B USD
3%
-2%
JP
M3 Inc
TSE:2413
1.3T JPY
29%
20%
AU
Pro Medicus Ltd
ASX:PME
11.4B AUD
69%
48%
US
Inspire Medical Systems Inc
NYSE:INSP
7B USD
-6%
-3%
US
Doximity Inc
NYSE:DOCS
4.4B USD
35%
29%
SE
Sectra AB
STO:SECT B
42.7B SEK
-39%
26%
US
Evolent Health Inc
NYSE:EVH
3.1B USD
1%
-7%
US
Goodrx Holdings Inc
NASDAQ:GDRX
2.8B USD
-3%
-1%
Country UK
Market Cap 190m GBP
Operating Margin
10%
Net Margin
6%
Country US
Market Cap 32.4B USD
Operating Margin
18%
Net Margin
22%
Country US
Market Cap 27.9B USD
Operating Margin
13%
Net Margin
10%
Country US
Market Cap 9B USD
Operating Margin
3%
Net Margin
-2%
Country JP
Market Cap 1.3T JPY
Operating Margin
29%
Net Margin
20%
Country AU
Market Cap 11.4B AUD
Operating Margin
69%
Net Margin
48%
Country US
Market Cap 7B USD
Operating Margin
-6%
Net Margin
-3%
Country US
Market Cap 4.4B USD
Operating Margin
35%
Net Margin
29%
Country SE
Market Cap 42.7B SEK
Operating Margin
-39%
Net Margin
26%
Country US
Market Cap 3.1B USD
Operating Margin
1%
Net Margin
-7%
Country US
Market Cap 2.8B USD
Operating Margin
-3%
Net Margin
-1%

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Return on Capital Comparison
Instem PLC Competitors

Country Company Market Cap ROE ROA ROCE ROIC
UK
Instem PLC
LSE:INS
190m GBP
6%
4%
11%
8%
US
Veeva Systems Inc
NYSE:VEEV
32.4B USD
13%
10%
10%
22%
US
Cerner Corp
NASDAQ:CERN
27.9B USD
14%
8%
12%
10%
US
Change Healthcare Inc
NASDAQ:CHNG
9B USD
-2%
-1%
1%
1%
JP
M3 Inc
TSE:2413
1.3T JPY
15%
11%
19%
20%
AU
Pro Medicus Ltd
ASX:PME
11.4B AUD
50%
36%
59%
87%
US
Inspire Medical Systems Inc
NYSE:INSP
7B USD
-4%
-3%
-7%
-32%
US
Doximity Inc
NYSE:DOCS
4.4B USD
15%
13%
18%
47%
SE
Sectra AB
STO:SECT B
42.7B SEK
34%
17%
-48%
-26%
US
Evolent Health Inc
NYSE:EVH
3.1B USD
-14%
-6%
1%
0%
US
Goodrx Holdings Inc
NASDAQ:GDRX
2.8B USD
-1%
-1%
-2%
0%
Country UK
Market Cap 190m GBP
ROE
6%
ROA
4%
ROCE
11%
ROIC
8%
Country US
Market Cap 32.4B USD
ROE
13%
ROA
10%
ROCE
10%
ROIC
22%
Country US
Market Cap 27.9B USD
ROE
14%
ROA
8%
ROCE
12%
ROIC
10%
Country US
Market Cap 9B USD
ROE
-2%
ROA
-1%
ROCE
1%
ROIC
1%
Country JP
Market Cap 1.3T JPY
ROE
15%
ROA
11%
ROCE
19%
ROIC
20%
Country AU
Market Cap 11.4B AUD
ROE
50%
ROA
36%
ROCE
59%
ROIC
87%
Country US
Market Cap 7B USD
ROE
-4%
ROA
-3%
ROCE
-7%
ROIC
-32%
Country US
Market Cap 4.4B USD
ROE
15%
ROA
13%
ROCE
18%
ROIC
47%
Country SE
Market Cap 42.7B SEK
ROE
34%
ROA
17%
ROCE
-48%
ROIC
-26%
Country US
Market Cap 3.1B USD
ROE
-14%
ROA
-6%
ROCE
1%
ROIC
0%
Country US
Market Cap 2.8B USD
ROE
-1%
ROA
-1%
ROCE
-2%
ROIC
0%

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.

See Also

Discover More